Clinical-Epidemiological Profile and Survival of Pediatric Cancer Patients in a High-Complexity Oncology Unit in Pernambuco, Brazil

Childhood cancer is a public health problem in both developed and developing countries. In Brazil, it is the leading cause of death from the disease among children and adolescents aged 0–19 years. Understanding the patient profile is strategic information for the development of public policies and for improving the quality of care provided. This cohort aimed to study and systematize the epidemiological data of pediatric cancer patients treated between 2011 and 2023. This was a retrospective observational cohort study with survival analysis based on medical records of pediatric patients treated at Hospital Dom Tomás. Data collected included demographic, clinical, treatment, and outcome variables, and survival analysis was performed in R using the Kaplan-Meier method and subsequently evaluated using univariable and multivariable Cox proportional hazards models. A total of 319 were included in the cohort, of which 254 were used for survival analysis. Most patients were male, aged 1–4 years and diagnosed with leukemia, of solid tumors, nephroblastoma and neuroblastoma were the most frequently represented. Chemotherapy (CTx) was the cornerstone of treatment across all malignancies, whereas bone marrow transplantation (BMT) was rarely indicated. The median overall survival was 134 months, and the median follow-up time was 59 months. Cancer type was the main prognostic factor for mortality, with myeloid leukemias and neuroblastoma independently associated with poorer survival, whereas age group, sex, and time from diagnosis to treatment were not independently associated with mortality. Survival outcomes were primarily influenced by cancer type. In contrast, age group, sex, and time from diagnosis to treatment were not independent prognostic factors. Larger cohorts are required to better elucidate these variables.

Authors

Institutions

Publication Details

Journal
Brazilian Journal of Oncology
Published
2026-11-18
DOI
https://doi.org/10.1055/s-0046-1829867
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical-Epidemiological Profile and Survival of Pediatric Cancer Patients in a High-Complexity Oncology Unit in Pernambuco, Brazil

Anna Caroline Figueiredo Falcão de Amorim, Michelle Ribeiro Viana Taveira, Sheilla Andrade de Oliveira, Marcos César De Souza Santos et al.
1 links
Brazilian Journal of Oncology
Global Cancer Incidence and Screening
article

Clinical-Epidemiological Profile and Survival of Pediatric Cancer Patients in a High-Complexity Oncology Unit in Pernambuco, Brazil

Anna Caroline Figueiredo Falcão de Amorim, Michelle Ribeiro Viana Taveira, Sheilla Andrade de Oliveira, Marcos César De Souza Santos, Norma Lucena‐Silva, Alan de Sousa Ribeiro, Marília Lopes Leal
article en

Abstract

Childhood cancer is a public health problem in both developed and developing countries. In Brazil, it is the leading cause of death from the disease among children and adolescents aged 0–19 years. Understanding the patient profile is strategic information for the development of public policies and for improving the quality of care provided. This cohort aimed to study and systematize the epidemiological data of pediatric cancer patients treated between 2011 and 2023. This was a retrospective observational cohort study with survival analysis based on medical records of pediatric patients treated at Hospital Dom Tomás. Data collected included demographic, clinical, treatment, and outcome variables, and survival analysis was performed in R using the Kaplan-Meier method and subsequently evaluated using univariable and multivariable Cox proportional hazards models. A total of 319 were included in the cohort, of which 254 were used for survival analysis. Most patients were male, aged 1–4 years and diagnosed with leukemia, of solid tumors, nephroblastoma and neuroblastoma were the most frequently represented. Chemotherapy (CTx) was the cornerstone of treatment across all malignancies, whereas bone marrow transplantation (BMT) was rarely indicated. The median overall survival was 134 months, and the median follow-up time was 59 months. Cancer type was the main prognostic factor for mortality, with myeloid leukemias and neuroblastoma independently associated with poorer survival, whereas age group, sex, and time from diagnosis to treatment were not independently associated with mortality. Survival outcomes were primarily influenced by cancer type. In contrast, age group, sex, and time from diagnosis to treatment were not independent prognostic factors. Larger cohorts are required to better elucidate these variables.

Brazilian Journal of OncologyVol. 22(CP)
Instituto de Tecnologia de Pernambuco (BR), Instituto Aggeu Magalhães (BR), Universidade Federal do Vale do São Francisco (BR)
Good health and well-being
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon